PANCREATIC CANCER

Adding FOLFIRINOX to nab-PG may improve outcomes in pancreatic cancer

“Patients with locally advanced pancreatic cancer must be treated with combination chemotherapy and, until proven otherwise, valid options are FOLFIRINOX (fluorouracil, leucovorin, irinotecan, oxaliplatin) and nab-paclitaxel plus gemcitabine (nab-PG). The latter followed by FOLFIRINOX is…

Read More